ACSL4 Antibodies

Santa Cruz Biotechnology provides a broad selection of ACSL4 monoclonal antibodies for research focused on acyl-CoA synthetase long-chain family member 4 (ACSL4). ACSL4 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ACSL4 is crucial for lipid metabolism and plays a significant role in the regulation of fatty acid activation and transport. Research has shown ACSL4's involvement in various cellular processes, including inflammation and cell signaling, making it an important target for research in metabolic disorders and cancer. Understanding ACSL4 function can provide insights into therapeutic strategies for diseases associated with lipid dysregulation. Researchers worldwide rely on ACSL4 monoclonal antibodies to advance their studies in lipid metabolism and related pathways. ACSL4 monoclonal antibodies enable detailed investigation of cellular mechanisms and potential therapeutic targets. ACSL4 monoclonal antibodies from Santa Cruz Biotechnology support researchers in making meaningful contributions to scientific understanding of metabolic diseases and cancer biology.